NCT05199012已完成不适用
Safety and Efficacy of Oral Supplementation With a Black Pepper Extract in Apparently Healthy Men and Women
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 86
- 试验地点
- 2
- 主要终点
- waist circumference
研究概览
简要总结
This study is a randomized, placebo-controlled, double-blind, two-arm trial of N=94 apparently healthy men and women to be recruited at a single investigational center in Northeast Ohio. Subjects will attend three study visits. During Visit 1, subjects will be screened for participation (i.e., medical history, physical exam, routine blood work, background baseline diet). Over the next 12 weeks, subjects will attend Visits 2 (baseline) and 3 (week 12), wherein assessments of body weight, waist circumference, urinary ketones, serum glucose, insulin, liver enzymes as well as other biomarkers of metabolic health, quality of life (SF-36 questionnaire), and various visual analog scales (VAS) for appetite, satiety, and cravings will be made.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Basic Science
- 盲法
- Single (Investigator)
入排标准
- 年龄范围
- 21 Years 至 65 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Provide voluntary signed and dated informed consent.
- •Be in good health as determined by medical history and routine blood chemistries.
- •Age between the ages of 21 and 65 (inclusive).
- •Body Mass Index of 25-34.99 (inclusive).
- •Body weight of at least 120 pounds.
- •Normotensive (seated, resting systolic blood pressure <140 mm Hg and diastolic blood pressure < 90 mm Hg. If the first measurement is slightly elevated above these limits, the subject will be given a brief (5 minute) rest period, and two more measurements will be taken. The average of all three measurements will be used to determine eligibility.
- •Normal seated, resting heart rate (<90 per minute).
- •Willing to duplicate their previous 24-hour diet, refrain from caffeine for 12 hr, abstain from exercise for 24 hr, and fast for 10 hours prior to each laboratory visit.
排除标准
- •History of unstable or new-onset cardiovascular or cardiorespiratory disease.
- •Individuals diagnosed with diabetes or other endocrine disorder.
- •Fasting blood sugar of > 126 mg/dL OR HgA1c of > 6.5%.
- •History of use of medications or dietary supplements known to affect glycemia or insulinemia.
- •Current use of amiodarone, anti-retroviral agents, corticosteroids, methotrexate, tamoxifen, valproate, amitriptyline (Elavil), codeine, desipramine (Norpramin), flecainide (Tambocor), haloperidol (Haldol), imipramine (Tofranil), metoprolol (Lopressor, Toprol XL), ondansetron (Zofran), paroxetine (Paxil), risperidone (Risperdal), tramadol (Ultram), venlafaxine (Effexor), cyclosporine, lithium, chlorzoxazone, theophylline, and bufuralol, cyclophosphamide, ifosfamide, barbiturates, bromobenzene, lovastatin (Mevacor), ketoconazole (Nizoral), itraconazole (Sporanox), fexofenadine (Allegra), triazolam (Halcion), glimepiride (Amaryl), glyburide (DiaBeta, Glynase PresTab, Micronase), insulin, pioglitazone (Actos), rosiglitazone (Avandia), etoposide, paclitaxel, vinblastine, vincristine, vindesine, amprenavir, indinavir, nelfinavir, saquinavir, cimetidine, ranitidine, diltiazem, verapamil, digoxin, erythromycin, cisapride (Propulsid),, loperamide (Imodium), quinidine, aspirin, clopidogrel (Plavix), dalteparin (Fragmin), enoxaparin (Lovenox), heparin, ticlopidine (Ticlid), warfarin (Coumadin), nevirapine, Pentobarbital (Nembutal), Phenytoin (Dilantin), Propranolol (Inderal), Rifampin, Amoxicillin (Amoxil, Trimox), Carbamazepine (Tegretol), Cefotaxime (Claforan), midazolam, diclofenac.
- •History of hyperparathyroidism or an untreated thyroid disease.
- •History of nephrotic syndrome or renal disease.
- •History of alcohol abuse within the past year.
- •History of malignancy in the previous 5 years except for non-melanoma skin cancer (basal cell cancer or squamous cell cancer of the skin).
- •Prior gastrointestinal bypass surgery (Lapband), etc.
- •Other known gastrointestinal or metabolic diseases that might impact nutrient absorption or metabolism, e.g., short bowel syndrome, diarrheal illnesses, history of colon resection, gastro paresis, Inborn-Errors-of-Metabolism (such as PKU).
- •Chronic inflammatory condition or autoimmune disease (e.g., rheumatoid arthritis, hepatitis, Crohn's disease, ulcerative colitis, Lupus, HIV/AIDS, etc.).
- •Female subjects who are pregnant, trying to become pregnant, or lactating. Women who participate in this study must agree to the use of contraception for the duration of the study and any woman that is sexually active will have to have a negative pregnancy test prior to enrolling. Women of childbearing age (any woman prior to menopause or surgically sterilized) regardless of their use of contraception will be provided a urine pregnancy test kit at their screening visit and take the test in private using the female lavatory after signing an informed consent.
- •Known sensitivity to any ingredient in the test formulations as listed in the Certificates-of- Analysis.
- •Currently participating in another research study with an investigational product or have been in another research study in the past 30 days.
- •Any other diseases or conditions that, in the opinion of the medical staff, could confound the primary endpoints or place the subject at increased risk of harm if they were to participate.
结局指标
主要结局
waist circumference
时间窗: Change from baseline to week 12
measurement of waist circumference in centimeters
triglycerides
时间窗: Change from baseline to week 12
measurement of triglycerides in blood
次要结局
- plasma free fatty acids(Change from baseline to week 12)
- body weight(Change from baseline to week 12)
- Body mass index(Change from baseline to week 12)
- urinary ketones(Change from baseline to week 12)
- liver enzymes(Change from baseline to week 12)
研究者
研究点 (2)
Loading locations...
相似试验
终止
不适用
Effect of Consuming a Bioactive Compound (EPP) on Joint Health in Healthy AdultsKnee DiscomfortNCT06650670Biosearch S.A.37
已完成
不适用
Study to Evaluate the Safety and Efficacy of a Proprietary "Joint Health" Dietary Supplement in Subjects With Joint and Connective Tissue PainJoint PainNCT03209895U.S. Nutraceuticals, LLC135
已完成
不适用
Study on the Effect of Rhubarb Extract on Stool Frequency and Biological Markers of Intestinal Function in Seniors With Low DefecationConstipation - FunctionalNCT05541991ortis45
招募中
不适用
Clinical Trial on a Food Supplement With Melatonin and Herbal Products to Improve Sleep QualitySleep DisordersNCT05459272Uriach Consumer Healthcare50
已完成
不适用
Possible Effects of the Dietary Supplement Magnesium Compared to PlaceboHealth PromotionNCT06332248Dan Hasson1,013